Young People With HIV Lament COVID Impact On Healthcare Workers

ZIMBABWE Young Positives (ZY+), a youth led network that advocates for the needs of Young People Living With HIV (A & YPLHIV) has bemoaned the pressure COVID-19 has exerted on health systems which has resulted in healthcare workers being overwhelmed and turning a blind eye to the Sexual Reproductive Health Rights (SRHR) needs of YPLHIV. By Patricia Mashiri Speaking during a media engagement on bodily autonomy funded by AIDS and Rights Alliance for Southern Africa (ARASA), Chido Katsiga, the Assistant Communications and Advocacy Officer ZY+ said the COVID-19 pandemic has…

Read More

No Evidence Of Drug Interaction Between ARVs And COVID-19 Vaccines- MoHCC

THE Ministry of Health and Child Care (MoHCC) has says there is no possibility of drug interaction if a Person Living with HIV (PLHIV) takes the COVID-19 vaccine, hence persons with HIV and on Antiretroviral Therapy (ART) should not hesitate to get the jab. By Michael Gwarisa Speaking during a virtual Media Briefing on HIV and COVID-19 vaccines that was organized by the Zimbabwe Association of Church Related Hospitals (ZACH), Mr Paul Chinakidzwa the Health Promotions Manager in the Ministry of Health said the COVID-19 vaccines for which WHO has…

Read More

MSF Donates Over USD 150,000 Worth Of TB Medication To NATPHARM

INTERNATIONAL medical humanitarian organization Médecins Sans Frontières (MSF) today handed over a consignment of TB medication to Zimbabwe’s National Pharmaceutical Company (NATPHARM). Health Reporter This is part of MSF’s contribution to ending TB in Zimbabwe. We are happy that Zimbabwe continues to make huge strides in containing and raising awareness on TB, and we congratulate the country for its removal from the list of countries with a high TB burden,” says MSF Country Representative, Dr. Reinaldo Ortuno.    The TB drugs donated today include first-line treatment for Drug sensitive TB and…

Read More

Covid-19 Impacts HIV Programming In Zim

THE National AIDS Council (NAC) and Zimbabwe National Network of People Living with HIV’s (ZNNP+) programs have not been spared by the ravaging COVID-19 pandemic. By Patricia Mashiri Speaking during a virtual meeting on the impact of COVID-19 on HIV programming Dr Bernard Madzima, Chief Executive Officer NAC said the COVID-19 pandemic brought negative affected HIV and AIDS programs in a negative way. COVID-19 was associated with the lockdowns, there was lots of uncertainty and misinformation that really impacted on programming as most HIV programs happen either at a health…

Read More

Inadequate COVID vaccines for developing countries affecting people with HIV

THE Joint United Nations Programme on HIV/AIDS (UNAIDS) said the limited access to COVID-19 vaccines for developing countries will have a negative impact on people living with HIV. By Staff Reporter In a report titled ‘Confronting Inequalities developing countries have been at a disadvantage over access to COVID-19 vaccines compared to rich countries which have monopolised access. “COVID-19 vaccines that could save millions of lives trickle into developing countries as new waves of infections threaten to overwhelm their under-financed health systems. At the end of June 2021, just 1% of…

Read More

Zim Removed From TB high Burden Countries List

THE World Health Organisation (WHO), has  removed Zimbabwe from the list of Tuberculosis (TB) high burden countries in its recent global updated list of high burden countries. By Patricia Mashiri The new lists are for 2021–2025 and replace those previously used between 2016 and 2020. Zimbabwe together with other high TB burden countries such as Cambodia, the Russian Federation transitioned  out of the list. Speaking to HealthTimes, Dr Charles Sandy, the Deputy Director, TB and HIV Services  in the Ministry of Health and Child Care (MoHCC) said there was some…

Read More

#BREAKING: Dapivirine, Vaginal Ring Approved For Use In Zimbabwe

IN what is likely to be a major breakthrough for Zimbabwe’s HIV response, the Dapivirine or Vaginal Ring, a tool meant to expand HIV prevention options for women has been approved for use in Zimbabwe, HealthTimes has learnt. By Michael Gwarisa The Vaginal ring was submitted to the Medicines Control Authority of Zimbabwe (MCAZ) for review on March, 5 2021 and according to MCAZ procedures, approval for a medical drug or innovation usually takes between three months or a few years, depending on the completeness of the technical information that…

Read More

Faith Based Organizations Strategic In Addressing HIV Information Gaps and Gender Inequality

Members from various churches gather at the women and girls symposium

RELGIOUS and Faith based Organisations (FBOs) have been identified as a key partner in addressing some of the information gaps rampart in the male population which has seen them lagging behind in terms of access to health information and services. By Michael Gwarisa Speaking during a virtual meeting for FBOs, UNAIDS Country Director, Sophia Mukasa Monico said Faith Based Organizations were deeply rooted in communities and they were better placed to address some of the inequalities with regards to access to essential health information, Gender Based Violence (GBV) and other…

Read More

Sexual Exploitation Exposes Zim’s Young Sex Workers Living With HIV To HIV Reinfection

SEX work has been on the increase in Zimbabwe, and for close to two decades due to a myriad of factors, chief among them being economic induced hardships, lack of employment opportunities and growing poverty levels, sex work has becoming the low hanging option for women and girls. Unlike in the old days when sex work used to be a preserve for adult women of consenting age, a growing number of adolescent girls in Peri-urban and farming communities in Zimbabwe are taking up sex work to survive. By Patricia Mashiri…

Read More

Zim To Introduce HIV Prevention Drug Thats Taken Once Every Month

Dr Nyaradzo Mgodi MBChB, MMed, Investigator of Record, HPTN-084 Zimbabwe – University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, and HPTN Executive Committee Member

ZIMBABWE is among the first countries set to introduce a new HIV preventative drug that will be taken once a month in a move that is likely to expand HIV prevention options for citizens. By Patricia Mashiri The new drug, Islatravir (MK-8591) belongs to a class of drugs called First-in-Class Nucleoside Reverse Transcriptase Translocation Inhibitor (NRTTI) With Multiple Mechanisms of Action. These multiple mechanisms of action contribute to its high potency against HIV-1 and drug-resistant variants, and its high barrier to resistance. Dr Nyaradzo Mgodi, Principal Investigator, University of Zimbabwe’s…

Read More